Intelligence Feed event · Commodity · 2026-10-01

    Albemarle Extends Monthly Loss to 20.6% at $105.78 Ahead of Q3 Results

    Question

    Albemarle Extends Monthly Loss to 20.6% at $105.78 Ahead of Q3 Results

    Direct answer

    Albemarle shares fell 1.71% to $105.78 on September 30, bringing the trailing one-month decline to 20.6% compared to an 8.47% decline across the broader specialty chemicals industry. The divergence highlights ongoing margin uncertainty across battery-grade lithium converters. Consensus models model a rebound to 16% revenue growth for the upcoming quarter, but equity trading reflects persistent spot commodity pricing headwinds and battery supply chain inventory adjustments.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-01
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Albemarle Extends Monthly Loss to 20.6% at $105.78 Ahead of Q3 Results”, revision 1, evidence through 2026-10-01. https://marketontology.com/market-events/2026-10-01/albemarle-extends-monthly-loss-to-20-6-at-105-78-ahead-of-q3-results-b72ca1

    COMMODITY
    Albemarle Extends Monthly Loss to 20.6% at $105.78 Ahead of Q3 Results
    Albemarle shares fell 1.71% to $105.78 on September 30, bringing the trailing one-month decline to 20.6% compared to an 8.47% decline across the broader specialty chemicals industry. The divergence highlights ongoing margin uncertainty across battery-grade lithium converters. Consensus models model a rebound to 16% revenue growth for the upcoming quarter, but equity trading reflects persistent spot commodity pricing headwinds and battery supply chain inventory adjustments.
    ALB
    Impact
    66
    OCT 1
    SIG
    85%
    ALB
    Albemarle Extends Monthly Loss to 20.6% at $105.78 Ahead of Q3 Results
    Albemarle shares fell 1.71% to $105.78 on September 30, bringing the trailing one-month decline to 20.6% compared to an 8.47% decline across the broader specialty chemicals industry. The divergence highlights ongoing margin uncertainty across battery-grade lithium converters. Consensus models model a rebound to 16% revenue growth for the upcoming quarter, but equity trading reflects persistent spot commodity pricing headwinds and battery supply chain inventory adjustments.
    → Spot lithium carbonate and hydroxide price pressure compresses realized refinery conversion spreads, driving Albemarle's 20.6% monthly equity decline.
    Impact
    Albemarle shares fell 1.71% to $105.78 on September 30, bringing the trailing one-month decline to 20.6% compared to an 8.47% decline across the broader specialty chemicals industry. The divergence highlights ongoing margin uncertainty across battery-grade lithium converters. Consensus models model a rebound to 16% revenue growth for the upcoming quarter, but equity trading reflects persistent spot commodity pricing headwinds and battery supply chain inventory adjustments.
    Affected
    ALB
    Transmission
    Spot lithium carbonate and hydroxide price pressure compresses realized refinery conversion spreads, driving Albemarle's 20.6% monthly equity decline.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ALBbattery-grade lithium pricing pass-through to specialty chemical marginsDown1-4wAlbemarle declined 1.71% to $105.78 and has fallen 20.6% over the past month

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month